BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1723261)

  • 1. The relation of argyrophilic proteins of nucleolar organizer regions (AgNORs) to the proportions of Ki-67 or DNA polymerase alpha-reacting cells in non-Hodgkin's lymphomas.
    Okabe Y; Nakamura S; Okumura H; Matano S; Kobayashi K; Ohtake S; Yoshida T; Matsuda T; Mizukami Y; Nonomura A
    Anticancer Res; 1991; 11(6):2031-5. PubMed ID: 1723261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas.
    Crocker J; Macartney JC; Smith PJ
    J Pathol; 1988 Feb; 154(2):151-6. PubMed ID: 3280766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions.
    Arora B; Kumar S; Jain R
    J Indian Med Assoc; 2006 Jan; 104(1):16-8, 24. PubMed ID: 16850861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The nucleolar organizer region in malignant non-Hodgkin's lymphoma].
    Jakić-Razumović J; Labar B; Cör A; Radman I
    Lijec Vjesn; 1992; 114(1-4):18-21. PubMed ID: 1343017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of cellular proliferative activity in 35 T-cell non-Hodgkin's lymphomas. Use of proliferating cell nuclear antigen and Ki-67 (MIB-1) antibodies and nucleolar organizer regions.
    Caulet-Maugendre S; Patey M; Granier E; Joundi A; Gentile A; Caulet T
    Anal Quant Cytol Histol; 1996 Oct; 18(5):337-44. PubMed ID: 8908304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of nucleolar organizer region staining and Ki-67 immunostaining in non-Hodgkin's lymphoma.
    Hall PA; Crocker J; Watts A; Stansfeld AG
    Histopathology; 1988 Apr; 12(4):373-81. PubMed ID: 2453436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell proliferation in colorectal adenomas containing invasive carcinoma.
    Risio M; Rossini FP
    Anticancer Res; 1993; 13(1):43-7. PubMed ID: 8097391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morphometric analysis of AgNORs in the lymph node lesions.
    Arora B; Jain R; Kumar S; Rekhi B; Arora H; Arora DR
    Adv Clin Path; 2002 Apr; 6(2):95-9. PubMed ID: 19753731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential demonstration of nucleolar organizer regions and Ki67 immunolabelling in non-Hodgkin's lymphomas.
    Janmohamed RM; Murray PG; Crocker J; Leyland MJ
    Clin Lab Haematol; 1990; 12(4):395-9. PubMed ID: 2081380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AgNORs predictive value of prognosis in non-Hodgkin's lymphoma according to the Kiel classification.
    Jakić-Razumović J; Petrovecki M; Dominis M
    Mod Pathol; 1995 Feb; 8(2):143-9. PubMed ID: 7777474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative study of AgNOR in differential diagnosis between non-Hodgkin's lymphoma and reactive hyperplasia.
    Gan X
    Chin Med J (Engl); 1995 Feb; 108(2):132-7. PubMed ID: 7774388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of Ki-67 and argyrophilic nucleolar organizer region staining for lymph node metastasis in gastric cancer.
    Kakeji Y; Korenaga D; Tsujitani S; Haraguchi M; Maehara Y; Sugimachi K
    Cancer Res; 1991 Jul; 51(13):3503-6. PubMed ID: 2054789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparative assessment of proliferating cell nuclear antigen, c-myc p62, and nucleolar organizer region staining in non-Hodgkin's lymphomas: a histochemical and immunohistochemical study of 200 cases.
    Korkolopoulou P; Patsouris E; Pangalis G; Tsenga A; Elemenoglou J; Thomas-Tsangli E; Spandidos D; Kittas C
    Hum Pathol; 1993 Apr; 24(4):371-7. PubMed ID: 7684020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of potential doubling time (Tpot), argyrophilic nucleolar organizer regions (AgNOR), and proliferating cell nuclear antigen (PCNA) as predictors of therapy response in canine non-Hodgkin's lymphoma.
    Vail DM; Kisseberth WC; Obradovich JE; Moore FM; London CA; MacEwen EG; Ritter MA
    Exp Hematol; 1996 Jun; 24(7):807-15. PubMed ID: 8647231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of argyrophilic nucleolar organizer regions (AgNORs) can be used to assess cellular proliferation as shown in rat thymic sections.
    Carbajo-Perez E; Alberca V; Vicente-Villardon V; Flores T; Carbajo S
    Histochem J; 1993 Aug; 25(8):548-53. PubMed ID: 8407364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleolar organizer regions in lymphomas.
    Crocker J; Nar P
    J Pathol; 1987 Feb; 151(2):111-8. PubMed ID: 2437276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleolar organizer regions in lymphomas: a quantitative study.
    Yekeler H; Ozercan MR; Yumbul AZ; Ağan M; Ozercan IH
    Pathologica; 1993; 85(1097):353-60. PubMed ID: 8233651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between the prognosis of retinoblastoma and proliferating cell nuclear antigen and argyrophilic protein at nucleolus organizer regions].
    Li D; Song X; Gao Y
    Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):293-6. PubMed ID: 10451965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of AgNOR and Ki-67 antigen as cell kinetic parameters in oral dysplasias and carcinomas.
    Zoeller J; Flentje M; Sinn P; Born IA
    Anal Cell Pathol; 1994 Jul; 7(1):77-88. PubMed ID: 7981138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteins associated with nucleolar organizer regions: practical application in tumor histopathology and relationship to biological properties of the tumor].
    Dubenskaia LI; Bazhenov SM
    Arkh Patol; 1992; 54(4):40-3. PubMed ID: 1444858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.